Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Critical Reviews in Oncology/Hematology|December 5, 2020
A systematic review and meta-analysis of PD-1/PD-L1 inhibitors in specific patient subgroups with advanced gastro-oesophageal junction and gastric adenocarcinomaV Formica, C Morelli, A Patrikidou, et al.
ESMO Open|November 14, 2024
PD-L1 thresholds predict efficacy of immune checkpoint inhibition in first-line treatment of advanced gastroesophageal adenocarcinoma. A systematic review and meta-analysis of seven phase III randomized trialsV Formica, C Morelli, L Fornaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 6, 2020
Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1-4 inhibitor in patients with advanced solid tumorsR Bahleda, F Meric-Bernstam, L Goyal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2006
The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphomaH-T Arkenau, G Chong, D Cunningham, et al.
British Journal of Cancer|April 30, 2009
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?S Postel-Vinay, H-T Arkenau, D Olmos, et al.
Critical Reviews in Oncology/Hematology|March 6, 2017
Biological and predictive role of ERCC1 polymorphisms in cancerV Formica, E Doldo, F R Antonetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2011
A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignanciesH-T Arkenau, R Plummer, L R Molife, et al.
ESMO Open|December 1, 2022
Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancerE Van Cutsem, H Hochster, K Shitara, et al.
ESMO Open|December 31, 2025
A phase II study of the AKT inhibitor TAS-117 in patients with advanced solid tumors and germline PTEN mutationsJ Ródon, H-T Arkenau, P Funchain, et al.
British Journal of Cancer|April 12, 2007
Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAXO Nehls, T Okech, C-J Hsieh, et al.
Pageof 3